Systematic Alpha Investments’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$474K Hold
1,029
0.02% 161
2025
Q4
$583K Hold
1,029
0.02% 141
2025
Q3
$460K Hold
1,029
0.02% 154
2025
Q2
$559K Hold
1,029
0.02% 143
2025
Q1
$510K Hold
1,029
0.02% 146
2024
Q4
$537K Hold
1,029
0.02% 143
2024
Q3
$506K Hold
1,029
0.02% 147
2024
Q2
$458K Hold
1,029
0.02% 155
2024
Q1
$411K Hold
1,029
0.02% 167
2023
Q4
$347K Hold
1,029
0.02% 177
2023
Q3
$301K Hold
1,029
0.02% 174
2023
Q2
$352K Hold
1,029
0.02% 171
2023
Q1
$263K Hold
1,029
0.01% 191
2022
Q4
$273K Buy
+1,029
New +$251K 0.01% 186
2022
Q3
Sell
-1,029
Closed -$207K 214
2022
Q2
$207K Hold
1,029
0.01% 202
2022
Q1
$310K Hold
1,029
0.02% 199
2021
Q4
$370K Sell
1,029
-2,076
-67% -$714K 0.02% 175
2021
Q3
$374K Buy
+3,105
New +$1.04M 0.02% 182

Other funds holding ISRG

Systematic Alpha Investments's ISRG Position: Q1 2026 in Review

Systematic Alpha Investments held its Intuitive Surgical (ISRG) position steady in Q1 2026 at 1,029 shares worth $474K. The position accounts for 0.02% of the portfolio, ranked #161.

Systematic Alpha Investments first reported a position in ISRG in Q3 2021 and has held it in 18 quarters since. The position peaked at $583K in Q4 2025. 2,305 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Systematic Alpha Investments held 1,029 shares of Intuitive Surgical worth $474K as of Q1 2026.
  • Systematic Alpha Investments left its Intuitive Surgical share count unchanged in Q1 2026.
  • Intuitive Surgical made up 0.02% of Systematic Alpha Investments's portfolio in Q1 2026, its #161 holding.
  • Systematic Alpha Investments first reported a position in Intuitive Surgical in Q3 2021 and has held it in 18 quarters since.
  • Systematic Alpha Investments's Intuitive Surgical position peaked at $583K in Q4 2025.
  • 2,305 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Systematic Alpha Investments's 13F filing for Q1 2026, filed 18 May 2026.